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Abstract
The Affordable Care Act (ACA) requires states to provide tobacco-cessation services without 
cost-sharing for pregnant traditional Medicaid-beneficiaries effective October 2010. It is unknown 
the extent to which obstetricians–gynecologists are aware of the Medicaid tobacco-cessation 
benefit. We sought to examine the awareness of the Medicaid tobacco-cessation benefit in a 
national sample of obstetricians–gynecologists and assessed whether reimbursement would 
influence their tobacco cessation practice. In 2012, a survey was administered to a national 
stratified-random sample of obstetricians–gynecologists (n = 252) regarding awareness of the 
Medicaid tobacco-cessation benefit. Results were stratified by the percentage of pregnant 
Medicaid patients. Chi-squared tests (p < 0.05) were used to assess significant associations. 
Analyses were conducted in 2014. Eighty-three percent of respondents were unaware of the 
benefit. Lack of awareness increased as the percentage of pregnant Medicaid patients in their 
practices decreased (range = 71.9%–96.8%; P = 0.02). One-third (36.1%) of respondents serving 
pregnant Medicaid patients reported that reimbursement would influence them to increase their 
cessation services. Four out of five obstetricians–gynecologists surveyed in 2012 were unaware of 
the ACA provision that required states to provide tobacco cessation coverage for pregnant 
traditional Medicaid beneficiaries as of October 2010. Broad promotion of the Medicaid tobacco-
cessation benefit could reduce treatment barriers.
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Tobacco use during pregnancy is the most common cause of preventable poor infant 
outcomes (e.g., preterm delivery, low birth weight) for which effective interventions exist 
(Chamberlain et al., 2013; USDHHS, 2014). In addition, prenatal smoking is associated with 
an estimated $122 million in excess infant health care costs at delivery in the United States 
(Adams et al., 2011). Significant disparities exist between low and high socioeconomic 
status women, particularly among women enrolled in Medicaid. Smoking prevalence during 
and after pregnancy was 17.6% and 23.4%, respectively, among Medicaid enrolled women 
versus 5.2% and 9.3% among privately insured women (Tong et al., 2013). Considering that 
Medicaid is the largest payer of prenatal and delivery healthcare and covers 45% of US 
births (The Henry J. Kaiser Family Foundation, 2014), the potential cost-savings of 
eliminating tobacco use and averting poor birth outcomes in the pregnant Medicaid 
population could be substantial (Adams et al., 2011; Lightwood et al., 1999).
The Affordable Care Act (ACA) requires states to provide tobacco-cessation services, 
including counseling and pharmacotherapy, without cost-sharing (i.e., no out-of-pocket 
costs) for pregnant traditional Medicaid beneficiaries effective October 2010 (USDHHS, 
2011). However, it is unknown the extent to which obstetricians–gynecologists are aware of 
the Medicaid tobacco-cessation benefit. We examined awareness of the Medicaid tobacco-
cessation benefit in a national sample of obstetricians–gynecologists and assessed whether 
reimbursement would influence their cessation practice. These findings can be useful to 
inform state maternal and child health and tobacco control efforts to reduce prenatal 
smoking.
Methods
During February–August 2012, the American College of Obstetricians and Gynecologists 
(ACOG) conducted a mailed survey of a national stratified-random sample of practicing 
obstetricians–gynecologists. Detailed methodology has been described previously 
(Coleman-Cowger et al., 2014). Briefly, 425 Collaborative Ambulatory Research Network 
(CARN) and 599 non-CARN members were invited to participate. CARN members are 
clinicians who volunteer to participate in ACOG surveys. Those invited received an 
introductory letter and up to 3 reminders. Response rates were 52% (CARN) and 31% (non-
CARN). The sample was further restricted to clinicians providing obstetrical care (n = 252, 
62% of respondents). The study was deemed exempt from review by ACOG and the Centers 
for Disease Control and Prevention Institutional Review Boards.
The survey focused on practice patterns and opinions related to patient tobacco use. The two 
survey questions analyzed for this study were: 1) “Are you aware that the ACA includes a 
provision that requires that pregnant women on Medicaid receive coverage for 
comprehensive smoking cessation services, including both counseling and pharmaco-
therapy?”; 2) “How much influence would reimbursement for cessation services for 
pregnant women on Medicaid under the ACA have on how you provide cessation services?” 
Results were stratified by the categorical response of the percentage of pregnant Medicaid 
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patients seen by respondents (0, 1–24%, 25–50%, >50%). Chi-squared tests (p < 0.05) were 
used to assess significant associations. Analyses were conducted in 2014.
Results
The majority of respondents were female (55.8%) and non-Hispanic White (84.3%); on 
average, respondents completed residency 19 years ago. Most respondents practiced in 
urban/suburban locations (81.0%), and 30.6% provided comprehensive primary care for 
women. About a quarter of respondents had >50% pregnant Medicaid patients; 61.6% had 
<50% pregnant Medicaid patients; and 13.2% had no pregnant Medicaid patients (Table 1).
Overall, 83% of obstetricians–gynecologists were unaware of the Medicaid tobacco-
cessation benefit for pregnant patients. Lack of awareness increased as the percentage of 
pregnant Medicaid patients in their practices decreased (range = 71.9%–96.8%; P = 0.02) 
(Table 1). Of respondents who saw pregnant Medicaid patients, one-third (36.1%) said 
reimbursement would increase their cessation services, and nearly 40% of those with >50% 
Medicaid patients said they would increase their services. A substantial fraction (30.2%) of 
respondents reported that cessation services would not change because reimbursement 
wouldn’t address ‘existing barriers to delivering service’, and 16.2% said they did not know 
how reimbursement would affect their cessation practices.
Discussion
We found that 4 out of 5 obstetricians–gynecologists surveyed in 2012 were unaware of the 
ACA provision that required states to provide tobacco cessation coverage for pregnant 
traditional Medicaid beneficiaries. However, one-third of respondents reported that 
reimbursement would influence them to increase cessation services, and an even greater 
percentage was seen among respondents who saw more Medicaid-enrolled patients. A 
previous study suggests that states with more comprehensive Medicaid coverage of tobacco 
cessation treatments, primarily through coverage of medications, resulted in 1.6 percentage 
point reduction (p < .05) in smoking before pregnancy and a small increase (<1 day) in 
infant gestation (Adams et al., 2013). In addition, as counseling will also be covered by the 
ACA mandate, a meta-analysis of 77 trials found that psychosocial interventions are 
effective in increasing the proportion of women who stop smoking in late pregnancy, and 
women who received psychosocial interventions had an 18% reduction in preterm births and 
infants born low birth weight (Chamberlain et al., 2013). Hence, reducing barriers to 
cessation treatments, as such through a comprehensive tobacco cessation benefit, could 
potentially allow more smokers to access treatment, increase cessation and improve infant 
outcomes among pregnant Medicaid enrollees.
Comprehensive and well-publicized benefits have shown larger effects in quitting among the 
general population of Medicaid-enrollees in the state of Massachusetts, including among 
young people and women (Land et al., 2010). For providers, this promotion included the 
development of fact sheets, with rate and billing codes, a pharmacotherapy pocket guide, 
and new intake and assessment protocols that were widely disseminated to health care 
systems and facilities (CDC, 2014). In addition, the state also directed educational 
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campaigns to consumers, tracked the use of the benefits, and provided feedback and 
recognition to providers who were regularly referring patients. Acknowledging the 
importance of raising awareness of the tobacco cessation benefit, the Centers for Medicare 
and Medicaid Services placed information on their website (Centers for Medicare and 
Medicaid Services, 2014) about Medicaid tobacco-cessation benefits for pregnant women 
and non-pregnant enrollees (Singleterry et al., 2014). However, broad state promotion and 
outreach of the Medicaid tobacco-cessation benefits, as noted earlier, for pregnant women 
can help to increase treatment utilization.
A substantial percentage of respondents reported that reimbursement would be insufficient 
to address existing barriers for cessation. Provider barriers that have been reported in a 
previous analysis of this data included time limitations to deliver cessation services in 
prenatal care visits and patient’s resistance to intervention (Coleman-Cowger et al., 2014). 
While reimbursement may improve service provision and broad promotion of the benefits 
may increase awareness, additional strategies, such as provider training (Tong et al., 2012) 
and healthcare system changes to facilitate stream-lined screening and treatment (Fiore et 
al., 2008), are also important to increase treatment utilization. Educational campaigns 
directed to consumers could also stress the importance and/or benefits of quitting smoking 
and support that prenatal care staff can provide.
This study has limitations to note. First, the study is limited by the low survey response rates 
(31–52%), which is consistent with previous ACOG surveys. However, nonresponse bias 
has been shown to be minimal among physician groups compared to other groups 
(Kellerman and Herold, 2001). Second, the sample size is small. For our analysis of how 
reimbursement would influence cessation services, we had limited power to test for 
differences in whether reimbursement would influence cessation services by percentage of 
Medicaid patients seen. Finally, these data are self-reported, and we did not verify 
information regarding awareness with their actual cessation or billing practices.
In conclusion, four out of five obstetricians–gynecologists surveyed in 2012 were unaware 
of the ACA provision that required states to provide tobacco cessation coverage for pregnant 
traditional Medicaid beneficiaries, and a third of respondents serving pregnant Medicaid 
patients reported that reimbursement would influence them to increase their cessation 
services. Promoting awareness of the Medicaid tobacco-cessation benefit among all medical 
providers who see pregnant and reproductive-aged women could help to reduce treatment 
barriers, thereby increasing cessation and improving maternal and infant health.
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